Back to search results

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

Abroad (travel likely)RecruitingPHASE2

Conditions

Lung Cancer (NSCLC) · Lung Cancer Non-Small Cell Cancer (NSCLC) · Lung Cancer (Non-Small Cell) · Lung Cancer - Non Small Cell · Lung Cancer Non Small Cell · Genomic Alterations

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Jessica J Lin, MD) · jjlin1@partners.org · 617-724-4000
    Contact: Principal Investigator (Jessica J Lin, MD)

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Daniel B Costa, MD, PhD) · dbcosta@bidmc.harvard.edu · 617-667-9236
    Contact: Principal Investigator (Daniel B Costa, MD, PhD)

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Julia K Rotow, MD) · Julia_Rotow@DFCI.HARVARD.EDU · 617-632-6555
    Contact: Principal Investigator (Julia K Rotow, MD)
Study leads

  • Jessics J Lin, MD

    Principal Investigator

    Massachusetts General Hospital

View source on ClinicalTrials.gov(opens in a new tab)